KRYS 8-K 2026-10-15

Krystal Biotech, Inc. (KRYS) 8-K dated 2026-10-15 — accession 0001711279-26-000064. This URL is the filing, not the KRYS hub.

Krystal Biotech, Inc. (KRYS) is a biotechnology company listed on NASDAQ.

Krystal Biotech, Inc. filed a 8-K on 2026-10-15. Accession 0001711279-26-000064.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported KRYS revenue for 2025-12-31 was $389.1M. Net income was $204.8M. Revenue was up 33.9% from 2024-12-31 to 2025-12-31. KRYS currently screens at market cap $10.17B.

Not investment advice. The KRYS SEC hub lists recent forms. The stock page is the research view.